SAVIENT PHARMACEUTICALS INC: cashflow_investing

Value{"amount": 13307000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2013-01-01 – 2013-03-31
Statuscurrent
EntitySAVIENT PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-13-220852 · Open the official SEC filing →
Retrieved: 2026-08-19T07:42:10.707571+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000722104/cashflow-investing/2013-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/46ffdc3a-3f3f-43b4-a472-895e02421b7a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies